Richard Barlow

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria

Clive Grattan, B. F. O’Donnell, David M. Francis et al. · British Journal of Dermatology · 2000 · 408 citations

Medicine, Pharmacology, Pharmacotherapy +13

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

U.K. guidelines for the management of cutaneous melanoma

D.L. Roberts, A. Anstey, Richard Barlow et al. · British Journal of Dermatology · 2002 · 327 citations · Full text

Medicine, Dermatology, Plastic Surgery +16